Screener Companies About
Nasdaq:CERS
Healthcare Medical Devices

CERUS CORP

A struggling industrial manufacturer showing flat revenue growth and persistent net losses despite substantial cash on hand.

■ Key Metrics

Revenue
$233.8M
Net Income
$-15.6M
Gross Profit
$233.8M
Operating Cash Flow
$4.8M
Total Assets
$221.9M
Shareholders' Equity
$65.0M
Cash & Equiv
$20.0M

⚖ Investment Thesis

Bull Case

The company possesses a robust balance sheet with $20M in cash and minimal capital expenditures of $3.7M, which could fund a turnaround if operational efficiencies are realized. The consistent revenue growth trend over the last four years suggests a growing market share or successful product adoption that has not yet translated to net income due to one-time costs or structural inefficiencies.

Bear Case

Investors should avoid this stock due to a deepening financial hole with a retained earnings deficit of -$1.08B and continuous annual net losses exceeding $15M. The operating structure is unsustainable as total expenses ($242.5M) now exceed gross profit ($233.8M), indicating that current business models are burning cash rather than generating value.

◉ About CERUS CORP

CERUS CORP operates within the industrial and manufacturing sectors, generating revenue primarily through specialized equipment sales and services. The company serves diverse markets with a gross profit of $233.8M against total revenue of $233.8M in 2025. Despite recent growth, the firm maintains a significant retained earnings deficit, indicating ongoing operational challenges.

⚙ Analysis

Management Discussion

While revenue increased from $186.8M in 2023 to $233.8M in 2025, the company continues to record a net profit deficit of $15.6M, highlighting a severe disconnect between top-line growth and bottom-line profitability. Operating expenses have surged to $242.5M, consuming nearly all gross profit and resulting in an operating loss of $8.7M before non-operating factors further reduced cash flow from operations to $4.8M.

Industry Overview

The industrial manufacturing sector faces intense competition and margin pressure, often requiring significant capital investment which this company has managed to avoid but at the cost of profitability. Companies in this space typically struggle with high fixed costs and cyclical demand, leading to volatile earnings as seen in CERUS CORP's declining losses.

☰ Financial Statements

Income Statement
Balance Sheet
Cash Flow
Metric2022202320242025
Revenue$188.3M$186.8M$201.3M$233.8M
Cost of Revenue$0$0$0$0
Gross Profit$188.3M$186.8M$201.3M$233.8M
Operating Expenses$222.4M$216.8M$215.5M$242.5M
Operating Income$-34.1M$-30.1M$-14.2M$-8.7M
G&A$83.3M$75.5M$75.9M$80.9M
Stock-Based Comp$24.5M$20.3M$22.9M$22.9M
D&A$3.0M$2.6M$1.9M$1.4M
Other OpEx$139.1M$141.3M$139.7M$161.6M
Non-Operating Income$-8.3M$-7.3M$-6.5M$-6.6M
Interest Expense$5.8M$8.4M——
Pre-Tax Income$-42.3M$-37.3M$-20.8M$-15.3M
Income Tax$488.0K$325.0K$205.0K$354.0K
Continuing Ops$-42.8M$-37.6M$-21.0M$-15.6M
Discontinued Ops$0$0$0$0
Net Income$-42.8M$-37.6M$-21.0M$-15.6M
Minority Interest$-46.0K$-158.0K$-43.0K$-10.0K
Net to Common$-42.8M$-37.5M$-20.9M$-15.6M
Metric2022202320242025
Current Assets$170.1M$144.4M$152.0M$174.4M
Cash & Equivalents$35.6M$11.6M$20.3M$20.0M
Accounts Receivable$34.4M$35.5M$29.8M$30.4M
Inventory$29.0M$39.9M$38.1M$56.1M
Prepaid Expenses$4.6M$3.2M$3.6M$5.0M
Other Current Assets$66.6M$54.2M$60.2M$62.9M
Long-Term Assets$47.9M$53.3M$48.9M$47.5M
PP&E (Net)$11.0M$8.6M$7.2M$9.2M
Goodwill$1.3M$1.3M$1.3M$1.3M
Operating Leases$12.5M$10.7M$8.4M$10.1M
Other LT Assets$23.2M$32.6M$32.0M$26.8M
Total Assets$218.1M$197.7M$200.9M$221.9M
Current Liabilities$117.1M$67.5M$63.6M$100.8M
Accounts Payable$33.0M$23.8M$21.7M$28.0M
Current Leases$2.1M$2.5M$2.3M$2.9M
Deferred Revenue$589.0K$2.0M$1.4M$1.3M
Other Current Liab$56.2M$20.0M$19.3M$43.3M
Long-Term Liabilities$32.5M$76.8M$80.4M$56.1M
LT Operating Leases$15.3M$13.8M$11.7M$10.2M
Other LT Liab$17.1M$63.0M$68.8M$45.9M
Total Liabilities$149.5M$144.3M$144.0M$156.9M
Shareholders' Equity$68.6M$53.4M$56.9M$65.0M
Retained Earnings$-1.01B$-1.04B$-1.07B$-1.08B
AOCI$-2.8M$-1.3M$-400.0K$-156.0K
Total L&E$218.1M$197.7M$200.9M$221.9M
Metric2022202320242025
Net Income (CFO)$-42.8M$-37.6M$-21.0M$-15.6M
Non-Cash Adjustments$12.4M$-16.6M$43.9M$-1.8M
Working Capital Changes$4.8M$11.1M$-11.6M$22.3M
Cash from Operations$-25.6M$-43.2M$11.4M$4.8M
Capital Expenditures$2.0M$4.6M$2.8M$3.7M
Cash from Investing$8.5M$8.6M$-8.1M$-6.2M
Cash from Financing$4.2M$10.7M$5.0M$231.0K
FX Effect$-727.0K$-128.0K$-191.0K$336.0K
Net Change in Cash$-13.7M$-24.0M$8.0M$-761.0K
Beginning Cash$51.0M$37.4M$13.4M$21.4M
Ending Cash$37.4M$13.4M$21.4M$20.6M

Frequently Asked Questions

How does CERUS CORP make money?

Core manufacturing operations driving $233.8M in revenue; specialized service contracts contributing to gross margins; government or enterprise procurement channels represented by high accounts receivable balances of $30.4M.

What are the main risks for CERS?

Persistent net losses of $15.6M eroding shareholder equity and deepening the retained earnings deficit to -$1.08B; high operating expenses of $242.5M exceeding gross profit, signaling potential margin compression or cost inefficiencies; heavy reliance on trade credit evidenced by accounts receivable nearing accounts payable levels.

What is CERS's competitive advantage?

Strong liquidity position with $20M in cash and equivalents providing operational flexibility; significant share-based compensation of $22.9M suggesting a workforce aligned with long-term recovery goals; low capital expenditures relative to asset base indicating efficient current operations.

Related Companies

Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.